Listen to the article
National Campaign Tackles Medicine Safety Amid Rising Health Misinformation
A nationwide initiative aimed at promoting safer medicine use has launched this week with a heightened focus on combating health misinformation and supporting evidence-based treatment decisions.
The fourth annual MedsAware: Deprescribing Action Week, running from March 16-20, represents a collaborative effort between Advanced Pharmacy Australia (AdPha) and the Australian Deprescribing Network (ADeN). The campaign seeks to stimulate meaningful conversations between consumers, carers, and healthcare providers about the benefits of deprescribing—the planned process of reducing unnecessary medications—while highlighting risks associated with polypharmacy and inappropriate medicine use.
This year’s campaign comes at a critical time as Australians increasingly navigate a digital landscape flooded with conflicting health information. According to healthcare experts, the rise in medical misinformation across online platforms presents significant challenges for patients making decisions about their treatment plans.
Associate Professor Tom Simpson, President of AdPha and a Fellow of the Australian and New Zealand College of Advanced Pharmacists, emphasized the crucial role pharmacists play in this environment. “Today, in an era where health information—and misinformation—is more accessible than ever, pharmacists play a vital role in helping people navigate conflicting advice and make evidence-based decisions about their medicines,” he said.
The campaign addresses a serious public health concern. Each year, approximately 250,000 Australians are hospitalized due to medication-related harm, with many cases directly linked to polypharmacy—the concurrent use of multiple medications—and inappropriate prescribing practices.
Dr. Emily Reeve, Chair of the Australian Deprescribing Network, acknowledged the positive trend of patients taking more interest in their medications while highlighting the challenges this creates. “It’s encouraging to see people taking an active interest in their medicines and their health,” she noted. “There are some excellent online resources, but with so much information available, it can be hard to know what’s trustworthy.”
Dr. Reeve stressed the value of healthcare professionals in helping patients sort through the abundance of information. “That’s where qualified health professionals make all the difference: helping people navigate the noise and together, make decisions that are safe, effective and right for them.”
The Royal Australian College of General Practitioners (RACGP) has also thrown its support behind the initiative. RACGP President Dr. Michael Wright observed a growing trend of patients seeking clarification on health information encountered online.
“For as long as we can remember, patients have come to their GPs seeking advice about information they’ve found or read elsewhere,” Dr. Wright said. “What has changed is our access to an ever-increasing source of information and knowing whether that information is correct or relevant.”
This evolution of the information ecosystem presents new challenges for patient care. “More and more patients are coming in genuinely unsure about what’s true, what’s misleading, and what they can trust,” Dr. Wright explained, adding that “misinformation is much harder to correct once it takes hold.”
The importance of deprescribing has gained recognition in recent years as healthcare systems worldwide grapple with aging populations often managing multiple chronic conditions. The process involves systematically reviewing medication regimens to identify and discontinue medications where potential harm outweighs benefit, particularly in vulnerable populations such as the elderly.
Through MedsAware 2026, the organizing bodies aim to encourage Australians to seek trusted advice from qualified health professionals when making decisions about their medications. The campaign emphasizes that decisions about medicine use, including deprescribing, should be made collaboratively between patients and healthcare providers based on evidence rather than unverified information found online.
As digital health information continues to proliferate, initiatives like MedsAware represent increasingly important efforts to ensure that Australians can access reliable guidance when navigating their medication journey.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.
13 Comments
Raising awareness of the risks associated with polypharmacy and inappropriate medicine use is crucial. Campaigns like this one play a vital role in promoting safer, more responsible medication management.
Absolutely, equipping both patients and providers with the right information is key to improving medication safety and outcomes.
This is a timely and much-needed initiative. Empowering consumers to make informed choices about their treatment is vital, especially with the spread of health misinformation online.
Promoting evidence-based medicine use and combating health misinformation are crucial initiatives. It’s great to see collaborative efforts like MedsAware focused on these important issues.
Absolutely, equipping consumers with accurate information to make informed decisions about their treatment is so important.
Polypharmacy and inappropriate medicine use are real risks that need to be addressed. I’m glad to see a focus on these challenges through the MedsAware campaign.
Yes, promoting more careful, evidence-based medication management is crucial for patient safety and wellbeing.
The rise of medical misinformation online is a real concern. Campaigns that encourage open dialogue between patients, caregivers and providers are a step in the right direction.
I agree. Fostering those meaningful conversations is key to help people navigate the flood of conflicting health info and make safe, appropriate treatment choices.
The campaign’s emphasis on fostering open dialogue between patients, caregivers and providers is a smart approach. Clear, evidence-based communication is key to combating medical misinformation.
I agree, transparent and collaborative relationships between all stakeholders are essential for safe, appropriate medication use.
Reducing unnecessary medication use through deprescribing is an important issue that deserves more attention. Initiatives like this can help raise awareness and drive positive change.
Deprescribing is an important but often overlooked issue. I’m glad to see it being addressed through this initiative. Reducing unnecessary medications can have real benefits for patient health.